Inventor
KREUTZER ROLAND
DE27 patents
⚠️ This page may combine multiple inventors who share the name “KREUTZER ROLAND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KREUTZER ROLAND
11 patentsUS8101584B2Jan 24, 2012
Method and medicament for inhibiting the expression of a given gene
KREUTZER ROLAND54 citations99
US8546143B2Oct 1, 2013
Compositions and methods for inhibiting expression of a target gene
KREUTZER ROLAND47 citations97
US8202980B2Jun 19, 2012
Method and medicament for inhibiting the expression of a given gene
KREUTZER ROLAND14 citations92
US8183362B2May 22, 2012
Method and medicament for inhibiting the expression of a given gene
KREUTZER ROLAND7 citations92
US8168776B2May 1, 2012
Method for making a 21 nucleotide double stranded RNA chemically linked at one end
KREUTZER ROLAND14 citations92
US8119608B2Feb 21, 2012
Method and medicament for inhibiting the expression of a given gene
KREUTZER ROLAND11 citations92
US8114981B2Feb 14, 2012
Method and medicament for inhibiting the expression of a given gene
KREUTZER ROLAND7 citations92
US8114851B2Feb 14, 2012
Method and medicament for inhibiting the expression of a given gene
KREUTZER ROLAND10 citations92
US8101742B2Jan 24, 2012
Method and medicament for inhibiting the expression of a given gene
KREUTZER ROLAND18 citations92
US8273870B2Sep 25, 2012
Compositions and methods for inhibiting expression of a mutant gene
KREUTZER ROLAND6 citations84
US8729037B2May 20, 2014
Method and medicament for inhibiting the expression of a given gene
KREUTZER ROLAND0 citations52
ALNYLAM PHARMACEUTICALS INC
11 patentsUS7829693B2Nov 9, 2010
Compositions and methods for inhibiting expression of a target gene
ALNYLAM PHARMACEUTICALS INC134 citations97
US7763590B2Jul 27, 2010
Compositions and methods for inhibiting expression of a mutant gene
ALNYLAM PHARMACEUTICALS INC15 citations84
US9133454B2Sep 15, 2015
Method and medicament for inhibiting the expression of a given gene
ALNYLAM PHARMACEUTICALS INC2 citations74
US8877726B2Nov 4, 2014
Method and medicament for inhibiting the expression of a given gene
ALNYLAM PHARMACEUTICALS INC3 citations74
US7994309B2Aug 9, 2011
Compositions and methods for inhibiting expression of a mutant gene
ALNYLAM PHARMACEUTICALS INC6 citations74
US7846907B2Dec 7, 2010
Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene
ALNYLAM PHARMACEUTICALS INC5 citations73
US9587240B2Mar 7, 2017
Compositions and methods for inhibiting expression of a target gene
ALNYLAM PHARMACEUTICALS INC2 citations72
US9902955B2Feb 27, 2018
Method and medicament for inhibiting the expression of a given gene
ALNYLAM PHARMACEUTICALS INC0 citations63
US7745418B2Jun 29, 2010
Compositions and methods for inhibiting viral replication
ALNYLAM PHARMACEUTICALS INC4 citations63
US9074213B2Jul 7, 2015
Compositions and methods for inhibiting expression of a target gene
ALNYLAM PHARMACEUTICALS INC2 citations62
US9902954B2Feb 27, 2018
Method and medicament for inhibiting the expression of a given gene
ALNYLAM PHARMACEUTICALS INC0 citations52
ALNYLAM EUROPE AG
3 patentsUS7348314B2Mar 25, 2008
Compositions and methods for inhibiting viral replication
ALNYLAM EUROPE AG45 citations95
US7473525B2Jan 6, 2009
Compositions and methods for inhibiting expression of anti-apoptotic genes
ALNYLAM EUROPE AG53 citations94
US7196184B2Mar 27, 2007
Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene
ALNYLAM EUROPE AG26 citations91